Sanjaya’s Voice in Media

The interim India-US trade deal lowers tariffs, restores exporter confidence, and emphasises policy clarity and stable frameworks to revive nutraceutical orders and enable long-term investment planning. 

The article explores how policy direction must translate into on-ground manufacturing strength, urging sharper execution, innovation focus, and industry-government alignment to unlock India’s growth potential.

The piece argues that the Union Budget should move beyond yearly announcements and become a long-term strategic framework guiding investment, competitiveness, and inclusive economic transformation.

India’s nutraceutical sector stands at a pivotal moment, where scaling production must be matched with regulatory clarity, quality benchmarks, and scientific validation to ensure sustainable global growth.

In an exclusive interview, Mr. Sanjaya Mariwala explains why reforming Access and Benefit Sharing regulations is vital to unlock plant-based research and responsible commercialization. 

The piece argues that US tariff distortions on Indian nutraceuticals highlight classification issues but also a chance for India to seize global demand and lead in preventive wellness exports. 

Consumers’ growing health awareness and demand for transparency are reshaping India’s nutraceutical sector, pushing brands toward science-backed, personalised, and trust-driven offerings 

India’s Union Budget 2025-26 must balance continuity with targeted reforms to drive growth. Mr. Sanjaya Mariwala highlights how policy stability, improved governance, and strategic initiatives can strengthen investor confidence, boost industrial growth, and accelerate India’s journey toward a multi-trillion-dollar economy.

The Union Budget 2025-26 has introduced measures aimed at strengthening India’s healthcare sector, including investments in medical education, digital health, and preventive care. Mr. Sanjaya Mariwala, President of IMC Chamber of Commerce and Industry, notes that while these initiatives are positive steps, they may not fully address the systemic challenges facing the healthcare system. He emphasises that increased funding, structural reforms, and long-term policy focus are essential to build a more resilient and equitable healthcare infrastructure.

India’s nutraceutical sector is poised for transformative growth, with the market expected to exceed US$100 billion by 2047. Achieving this potential will require stronger regulations, robust innovation, and greater consumer awareness. Mr. Sanjaya Mariwala, Executive Chairman and Managing Director of OmniActive Health Technologies, emphasises that strategic collaboration between government and industry players will be key to building a sustainable and competitive nutraceutical ecosystem.

Mr. Sanjaya Mariwala highlights that India’s recent GST reforms—exempting consultations, diagnostics, and telemedicine—mark a pivotal shift towards affordable, accessible healthcare. By reducing tax burdens on nutraceuticals, the government is positioning preventive nutrition as a mainstream practice. However, he notes, to truly transform healthcare, India must invest in workforce skilling, infrastructure, and trust-building. The future of Indian healthcare lies in integrating digital health, preventive care, and evidence-based wellness models.

As India’s health-conscious consumers demand more safety, transparency, and efficacy, branded ingredients are increasingly becoming the differentiator in the dietary supplements sector. Mr. Sanjaya Mariwala explore how proprietary, clinically backed ingredients are reshaping market trust, what challenges remain—from awareness to regulation—and what steps the industry must take to ensure sustainable growth.